Article Versions Notes

Detsika MG, Nikitopoulou I, Veroutis D, Vassiliou AG, Jahaj E, Tsipilis S, Athanassiou N, Gakiopoulou H, Gorgoulis VG, Dimopoulou I, et al. Increase of HO-1 Expression in Critically Ill COVID-19 Patients Is Associated with Poor Prognosis and Outcome. Antioxidants. 2022; 11(7):1300. https://doi.org/10.3390/antiox11071300

Detsika, Maria G., Ioanna Nikitopoulou, Dimitris Veroutis, Alice G. Vassiliou, Edison Jahaj, Stamatis Tsipilis, Nikolaos Athanassiou, Hariklia Gakiopoulou, Vassilis G. Gorgoulis, Ioanna Dimopoulou, and et al. 2022. "Increase of HO-1 Expression in Critically Ill COVID-19 Patients Is Associated with Poor Prognosis and Outcome" Antioxidants 11, no. 7: 1300. https://doi.org/10.3390/antiox11071300

Detsika, M. G., Nikitopoulou, I., Veroutis, D., Vassiliou, A. G., Jahaj, E., Tsipilis, S., Athanassiou, N., Gakiopoulou, H., Gorgoulis, V. G., Dimopoulou, I., Orfanos, S. E., & Kotanidou, A. (2022). Increase of HO-1 Expression in Critically Ill COVID-19 Patients Is Associated with Poor Prognosis and Outcome. Antioxidants, 11(7), 1300. https://doi.org/10.3390/antiox11071300